SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001005150-03-000005
Filing Date
2003-01-03
Accepted
2003-01-03 16:58:11
Documents
7

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sch13d.txt SC 13D 27487
3 EXHIBIT 99.1 ex99-1.txt EX-99.1 33674
4 EXHIBIT 99.2 ex99-2.txt EX-99.2 45855
5 EXHIBIT 99.3 ex99-3.txt EX-99.3 36277
6 EXHIBIT 99.4 ex99-4.txt EX-99.4 42210
7 EXHIBIT 99.5 ex99-5.txt EX-99.5 8379
8 EXHIBIT 99.6 ex99-6.txt EX-99.6 108107
  Complete submission text file 0001005150-03-000005.txt   304704
Mailing Address 7 POWDER HORN DRIVE P O BOX 4914 WARREN NJ 07059
Business Address 7 POWDER HORN DR WARREN NJ 07059 7322711001
CELGENE CORP /DE/ (Filed by) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9640 MEDICAL CNTR SR STE 200 ROCKVILLE MD 20850
Business Address 9640 MEDICAL CNTR DR STE 200 ROCKVILLE MD 20850 3012179858
ENTREMED INC (Subject) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-46247 | Film No.: 03503629
SIC: 2836 Biological Products, (No Diagnostic Substances)